Status:
WITHDRAWN
Transverse Abdominal Plane Anesthesia for Abdominal Wall Reconstruction
Lead Sponsor:
Chester Mays
Conditions:
Hernia, Ventral
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The aim of this study is to evaluate the short-term postoperative outcomes in the abdominal wall reconstruction population using an intraoperative local anesthetic infusion. A prospective randomized d...
Detailed Description
One group will be the control group (group A) and the other will be the study group (group B). Neither patient nor physician will know which group they have been assigned. Informed consent will be obt...
Eligibility Criteria
Inclusion
- Subjects to be included are all competent patients, 18 years of age or older, who undergo abdominal component separation for a hernia.
Exclusion
- Patients who are not having abdominal component separation or are receiving another form of regional anesthesia will be excluded.
- Patients younger than 18 years of age will be excluded.
- Amide-type local anesthetics, such as bupivacaine, are metabolized by the liver.
- Patients' with hepatic disease, because of their inability to metabolize local anesthetics normally, are at a greater risk of developing toxic plasma concentrations and will therefore be excluded from the study.
Key Trial Info
Start Date :
January 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2017
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT02274077
Start Date
January 1 2016
End Date
June 1 2017
Last Update
July 11 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Rochester Medical Center
Rochester, New York, United States, 14642